Aaron Tosso

INARI Account Manager Memphis Area

[Aaron Tosso @XrayandAngios]

@The_DocHolliday @WindhorstESPN @memgrizz @JaMorant ja is cooked

[Aaron Tosso @XrayandAngios]

@The_DocHolliday @ShamsCharania @memgrizz @JaMorant It's a risk versus reward. No one wants to take the risk and give up anything for JA. He doesn't have the value he should. I think we can agree on that.

[Jeffrey F. B. Chick, MD, MPH @CHICKVIR]

RevCore mechanical thrombectomy catheter may effectively and safely debulk organized or in-stent portomesenteric venous thrombi, restoring patency in challenging splanchnic venous thrombosis.

https://t.co/Ok3XMyA9Ti

@KeckMedicineUSC @UWRadiology @CVIR_Journal @InariMedical

[Aaron Tosso @XrayandAngios]

@Lane_Kiffin Purple, Gold or white visor?

[LSU Football @LSUfootball]

The head coach of your Fighting Tigers. @Lane_Kiffin is Callin' Baton Rouge!

[Aaron Tosso @XrayandAngios]

@ohokvontae @ghylton Are you for real?

[Aaron Tosso @XrayandAngios]

@ohokvontae Tdifferent points in their career one actually has rings and doesn't and probably never will

[Aaron Tosso @XrayandAngios]

@SainAsylum Ja's talking from the bench ,Clay is talking from the NBA finals big difference doofus

[Aaron Tosso @XrayandAngios]

@SainAsylum Ja needs to be traded, we are wasting our time with him. He is never going to change or be the leader we want in Memphis.. he will go down as one of the biggest "wasted his talent" guys in NBA history.

[Aaron Tosso @XrayandAngios]

@The_DocHolliday @SainAsylum @JaMorant @KlayThompson Ja will never a championship.. unless he changes

[Inari, now part of Stryker @InariMedical]

2 weeks until our next #ClotWarriorAcademy webinar!

We’ll discuss the latest innovations in arterial thrombectomy and clinical strategies, featuring key insights on the #Artix device and its impact on #ALI treatment. Gain valuable perspectives through real-world applications of the Artix thrombectomy system, including:
- Device selection considerations
- Procedural decision-making
- Patient outcomes across a range of challenging anatomies

Join us to deepen your understanding and enhance your clinical approach with practical knowledge from industry experts.

Register here for 4PM PT/7PM ET: https://t.co/J3S20LaAkL
Register here for 6PM PT/9PM ET: https://t.co/xDJII7hIT1

#InariMedical #MedicalInnovation #AllInOne #Artix #ALI #CWA

[Inari, now part of Stryker @InariMedical]

You’ve worked too hard to settle. #Artix is designed to help you address common challenges of arterial thrombectomy that threaten procedural success—and your patients’ health, including:
• The need to minimize the risk of arterial clot migration*
• Ineffective revascularization in a single session
• Blood loss

More on Artix: https://t.co/VskqvjUlCi

#AllInOneAdvantage #InariMedical #MedicalInnovation

*According to benchtop testing compared to control. Internal data on file.

[Inari, now part of Stryker @InariMedical]

“I enjoyed using Artix and will definitely use it again…” — Jonathan Bowman, MD

Using the #Artix Thrombectomy system, Dr. Bowman successfully restored arterial flow in a patient with a 45cm occlusion. #Artix is the all-in-one solution for arterial #clot treatment.​

Case highlights:​
- 50 minute device time​
- Mechanical thrombectomy and aspiration​
- No lytics used

Learn more about Artix: https://t.co/VskqvjUlCi

[Inari, now part of Stryker @InariMedical]

Exceptional treatment flexibility & control with #Artix thrombectomy system!

The dual mechanical thrombectomy + aspiration toolkit is designed to effectively remove both acute and chronic clots (1).

• Low-profile, trackable, kink-resistant sheath expands treatment options.
• Over-the-wire mechanical element ensures complete access and precise control.
• Covered funnel catheter provides proximal flow restriction to reduce clot migration risk (2).

More on Artix: https://t.co/VskqvjUlCi

#AllInOneAdvantage #InariMedical #MedicalInnovation

Note: 1. Designed to remove acute to chronic arterial clots. Benchtop testing internal data on file. Narula et al. JACC 2020;72:2153-63 2. According to benchtop testing compared to control. Data on file.

[Aaron Tosso @XrayandAngios]

#PEERLESS

This RCT data validates all those who believed in Flowtriever’s ability to safely and effectively treat patients early on. For some, this RCT will create a new set of believers.

[Inari, now part of Stryker @InariMedical]

#PEERLESS results show a clear win for #FlowTriever on the 5-component win ratio primary endpoint. Patients experienced:

- 3X fewer deteriorations and/or therapy escalations
- Better, faster recovery of symptoms & hemodynamics
- Less ICU utilization, hospital LOS, and readmission burden.

Join us live tomorrow at #TCT2024 to learn more: https://t.co/rMuuRHlSBf
@TCTConference

[Inari, now part of Stryker @InariMedical]

#TCT2024 is here! We’re gearing up for an exciting week ahead as we await results from the #PEERLESS RCT. Come by booth 713 to learn more!

See you there!
@TCTConference

[Inari, now part of Stryker @InariMedical]

We're just 5 days away from #PEERLESS results, a Randomized Controlled Trial (RCT) of FlowTriever vs. catheter-directed thrombolytics (CDT) in #pulmonaryembolism.

Don't miss the late-breaking results during #TCT2024!

@TCTConference
@wissamj123

[Inari, now part of Stryker @InariMedical]

Total episode care costs for endovascular treatment were nearly $3,400 lower with #ClotTriever compared to continuous aspiration vacuum thrombectomy. The cost savings with #ClotTriever were driven by lower device costs, fewer complications, minimal adjunctive procedures, and reduced readmission rates—key factors when aiming to reduce procedure time for #DVT treatment using aspiration thrombectomy.

[Inari, now part of Stryker @InariMedical]

Exciting day at Inari HQ! We were thrilled to welcome these distinguished physicians for the #InariExperience today.

Great discussions and insights—thank you for joining us!

[Inari, now part of Stryker @InariMedical]

The RevCore thrombectomy catheter is the first mechanical thrombectomy device engineered specifically for venous stent thrombosis, offering safe and effective clot removal while restoring stent patency in a single session. With its ability to handle various stent types and thrombus chronicities, #RevCore sets a new standard in treating venous in-stent thrombosis.

Learn More: https://t.co/IxV6qaur7b

#MedicalInnovation #InariMedical